Merck (MRK) Tops Q4 EPS by 24c
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $125.07 -0.73%
Revenue Growth %: +3.6%
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +3.6%
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $1.80, $0.24 better than the analyst estimate of $1.56. Revenue for the quarter came in at $13.5 billion versus the consensus estimate of $13.46 billion.
GUIDANCE:
Merck sees FY2022 EPS of $7.12-$7.27, versus the consensus of $7.29. Merck sees FY2022 revenue of $56.1-57.6 billion, versus the consensus of $56.64 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
- Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
